Pflug Koory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pflug Koory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,212	Closed	-$109K	–	472
2022 Q1	$109K	Hold	1,212	–	–	0.05%	199
2021 Q4	$136K	Hold	1,212	–	–	0.07%	189
2021 Q3	$152K	Hold	1,212	–	–	0.08%	176
2021 Q2	$164K	Hold	1,212	–	–	0.09%	179
2021 Q1	$164K	Hold	1,212	–	–	0.09%	173
2020 Q4	$171K	Hold	1,212	–	–	0.1%	174
2020 Q3	$135K	Hold	1,212	–	–	0.09%	176
2020 Q2	$136K	Buy	+1,212	New	+$119K	0.1%	172

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Pflug Koory's XBI Position: Q2 2022 in Review

Pflug Koory sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 1,212 shares — an estimated $109K sold.

Pflug Koory first reported a position in XBI in Q2 2020 and held it in 8 quarters. The position peaked at $171K in Q4 2020. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Pflug Koory reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Pflug Koory sold 1,212 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $109K.
Pflug Koory first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 8 quarters.
Pflug Koory's State Street SPDR S&P Biotech ETF position peaked at $171K in Q4 2020.
706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Pflug Koory's 13F filing for Q2 2022, filed 1 Aug 2022.